Concentration of evobrutinib, a BTK inhibitor, in cerebrospinal fluid during treatment of patients with relapsing multiple sclerosis in a phase 2 study
Titel:
Concentration of evobrutinib, a BTK inhibitor, in cerebrospinal fluid during treatment of patients with relapsing multiple sclerosis in a phase 2 study
Auteur:
Piasecka-Stryczynska, Karolina Rejdak, Konrad Dyroff, Martin Hyvert, Yann Holmberg, Kristina Mandel, Matthew Cunha, Carolina Mitchell, David Martin, Emily Montalban, Xavier